Conjugated Estrogens

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

Access all COS suppliers
Check all USDMF suppliers

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 14 USDMF, 1 CEP/COS, 2 EU WC, 1 KDMF, 7 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 38 FDA Orange Book, 44 Europe, 10 Canada, 14 South Africa, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 20MG BASE;0.45MG, TABLET;ORAL - 0.3MG, TABLET;ORAL - 0.45MG, TABLET;ORAL - 0.625MG, TABLET;ORAL - 0.9MG, TABLET;ORAL - 1.25MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 2 DKSH, 1 Jai Radhe Sales, 3 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 30 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 27 Direct Compression, 27 Controlled & Modified Release, 18 Thickeners and Stabilizers, 16 Granulation, 15 Solubilizers, 15 Co-Processed Excipients, 13 Film Formers & Plasticizers, 10 Topical, 10 Lubricants & Glidants, 10 Disintegrants & Superdisintegrants, 10 Taste Masking, 8 Parenteral, 6 Chewable & Orodispersible Aids, 5 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 3 Rheology Modifiers, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

50 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

12 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM

3 EDQM

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Aspen Pharmacare Holdings

South Africa

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Conjugated Estrogens

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Study Phase : Approved

Sponsor : Avion Pharmaceuticals

Deal Size : Undisclosed

Deal Type : Partnership

DEALS_DEV

Aspen Concludes Strategic Partnership with U.S-Based Avion Pharmaceuticals

Details : Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy d...

Brand Name : Cenestin

Molecule Type : Small molecule

Upfront Cash : Undisclosed

November 12, 2020

Lead Product(s) : Conjugated Estrogens

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Highest Development Status : Approved

Sponsor : Avion Pharmaceuticals

Deal Size : Undisclosed

Deal Type : Partnership

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Virtual Booth

Find Clinical Drug Pipeline Developments & Deals for Conjugated Estrogens